This inventor holds 1 USPTO granted patent. Top assignee: Diabeloop. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovative Mind of Mathieu Cattelan
Introduction
Mathieu Cattelan is a notable inventor based in Grenoble, France. He has made significant contributions to the field of medical technology, particularly in drug dosage determination. His innovative approach has led to the development of a patented system that enhances the safety and efficiency of drug administration.
Latest Patents
Cattelan holds a patent for a "Computerized system and method for the determination of a drug dosage, and computer program." This system includes a dose determination module that calculates possible drug dosages, a security module that checks for triggered security thresholds, and a notification module that alerts users when necessary. The communication module is designed to receive drug dosage data from a dispensing device, ensuring a comprehensive approach to medication management. This patent highlights Cattelan's commitment to improving healthcare through technology.
Career Highlights
Mathieu Cattelan is currently employed at Diabeloop, a company focused on developing innovative solutions for diabetes management. His work at Diabeloop emphasizes the integration of technology in healthcare, aiming to provide better outcomes for patients. Cattelan's expertise in computerized systems has positioned him as a key player in the medical technology sector.
Collaborations
Cattelan collaborates with Gilles Gaillardon, a fellow innovator in the field. Their partnership exemplifies the importance of teamwork in driving advancements in technology and healthcare.
Conclusion
Mathieu Cattelan's contributions to drug dosage determination through his patented system reflect his dedication to innovation in medical technology. His work at Diabeloop and collaborations with other professionals further enhance the impact of his inventions.